Endocrinology · Stockbridge, GA
NPI
1942301759
Since 2006
Specialty
Endocrinology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
550 Eagles Landing Pkwy Ste 110
Stockbridge, GA, 30281
Phone (770) 389-9494
Groups this clinician bills Medicare through
Medicare paid, 2024
$208K
3,159 services
Medicare patients, 2024
622
Average age 71
Drug cost, 2024
$9.3M
11,772 prescriptions
Company payments, 2025
$5,321
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald S Watts was code 99214 (office e&m - established), 1,281 times for 551 patients. In total Ronald S Watts billed 3,159 services in 13 codes, and Medicare paid $208K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,281 | 551 | $91.56 | $117K |
| 82962 Clinical Chemistry | Office | 746 | 312 | $3.18 | $2,372 |
| 95251 Test - Miscellaneous | Office | 441 | 215 | $25.49 | $11K |
| 95250 Test - Miscellaneous | Office | 246 | 96 | $114.29 | $28K |
| 99215 Office E&M - Established | Office | 149 | 74 | $137.67 | $21K |
| 99204 Office E&M - New | Office | 121 | 121 | $121.32 | $15K |
| 76536 Ultrasound - Nonspecific | Office | 120 | 115 | $81.35 | $9,762 |
| 10005 Other Organ Systems | Office | 19 | 18 | $98.73 | $1,876 |
| 99213 Office E&M - Established | Office | 18 | 13 | $69.91 | $1,258 |
By year: 2022 $231K for 7,083 services; 2023 $193K for 3,038 services; 2024 $208K for 3,159 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 746 | 312 | $3.18 | $2,372 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald S Watts prescribed most often to Medicare patients was Levothyroxine Sodium, with 846 prescriptions and refills. In total Ronald S Watts wrote 11,772 Medicare prescriptions that cost $9.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 846 | 2,139 | 244 | $7,226 |
| Mounjaro Tirzepatide | 531 | 678 | 101 | $712K |
| Trulicity Dulaglutide | 496 | 775 | 128 | $754K |
| Atorvastatin Calcium Generic | 474 | 1,180 | 162 | $4,071 |
| Farxiga Dapagliflozin Propanediol | 442 | 762 | 116 | $427K |
| Ozempic Semaglutide | 415 | 663 | 115 | $633K |
| Metformin Hcl Generic | 400 | 1,016 | 126 | $2,173 |
| Jardiance Empagliflozin | 390 | 729 | 115 | $424K |
| Rosuvastatin Calcium Generic | 344 | 898 | 118 | $3,857 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 323 | 710 | 110 | $48K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 322 | 765 | 154 | $43K |
| Novolog Flexpen Insulin Aspart | 274 | 539 | 109 | $78K |
| Losartan Potassium Generic | 245 | 637 | 77 | $1,849 |
| Glipizide Er Glipizide | 222 | 506 | 74 | $2,395 |
| Ezetimibe Generic | 221 | 610 | 74 | $3,376 |
Brand drugs: 5,976 claims; generic drugs: 4,850 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald S Watts $5,321 ($5,321 in general payments such as food, travel and fees) from 27 companies. The largest payer was Novo Nordisk Inc with $762.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 25 | $762 |
| Amgen Inc. AMGN | 22 | $589 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 16 | $537 |
| Xeris Pharmaceuticals, Inc. | 19 | $475 |
| Corcept Therapeutics CORT | 12 | $390 |
| Ascendis Pharma Endocrinology Inc ASND | 10 | $313 |
| Lilly USA, LLC LLY | 13 | $301 |
| Medtronic, Inc. MDT | 5 | $267 |
| Insulet Corporation PODD | 3 | $256 |
| Radius Health, Inc. | 7 | $205 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.